Effect of Transcutaneous Auricular Vagus Nerve Stimulation Application on Respiratory Functions in Stroke Patients
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-80
SponsorFenerbahce University
About this trial
The purpose of this study is to evaluate the effectiveness of Transcutaneous Auricular Vagus Nerve Stimulation (TAVSS) in improving respiratory muscle strength and function in chronic stroke patients. It aims to explore TAVSS as a potential complementary approach in enhancing rehabilitation outcomes for this population.
Eligibility criteria
Qualifiers
Being a chronic stroke patient with an ischemic or hemorrhagic stroke diagnosis made 1-3 years ago
Having been diagnosed with stroke for the first time
Ability to understand and follow simple verbal instructions
Being between the ages of 40 and 80
Disqualifiers
Presence of infection, ulcer, or scar on the auricle
Metallic implants in the skull, hypersensitivity, injury, or inflammation inside the ear
Chronic pulmonary and/or cardiac diseases
Resting heart rate below 60 beats per minute
Trial design
Treatments tested in this trial
- Transcutaneous Auricular Vagus Nerve Stimulation
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov